Use of Stem Cells to Treat Left Ventricular Hypertrophy

Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2023, Vol 4, Issue 3

Abstract

Left Ventricular Hypertrophy is a multifactorial condition involving genetic and signaling pathways. Current recommendations for treating hypertensive LVH include ACE inhibitors, RAS and CCBs. Despite numerous drug therapies for ventricular hypertrophy, patients often deteriorate and experience a decline in ventricular function ultimately leading to heart failure. For this reason, alternative therapies must be investigated. Stem cells possess the potential to divide at a high capacity, self-renew and differentiate into numerous cardiac cell lineages. Furthermore, stem cells are connected to ventricular remodeling and are vital in maintaining the homeostasis of the heart. Further examination of the role of stem cells in LVH could result in the development of targeted therapeutic interventions for prevention or reversal of the phenomenon.

Authors and Affiliations

Hetvi Solanki1, Vincent S Gallicchio1*

Keywords

Related Articles

Case of Successful Treatment of a Patient with Subchondral Fracture of the Knee Joint using Subchondral Platelet-Rich Plasma Injection

We report the treatment of a patient with a pronounced knee pain syndrome related to a subchondral knee joint fracture in the context of osteoarthritis. Traditional treatment methods for this pathology have demonstrated...

The Jounced Entrails-Intestine in COVID-19

Coronavirus disease 2019 (COVID-19), initiated by contemporary coronavirus is a pandemic which engenders severe respiratory disease. SARS-CoV-2 preponderantly transmits through airborne particles and mammoth respirator...

Platelet Rich Plasma- Platelet Concentrate Therapy in COPD: An Observational Cohort Study

Objective: Current management of Chronic Obstructive Pulmonary Disease (COPD) is aimed at improving symptoms and preventing exacerbations, yet those treatments cannot alter the natural progression of lung function decl...

Jejunal Atresia with Hirschsprung’s Disease: A Case Report

A rare case of congenital intestinal atresia associated with Hirschsprung disease was reported. A 0-day-old boy who was diagnosed to have intestinal atresia and he underwent intestinal anastomosis. The movement of the...

The Application of Transgenesis to Abraham Trembley’s Hydra, an Ancient Animal Model for the Study of Regeneration that has now entered the 21st Century

Developmental biology and regenerative biology began with the studies of Abraham Trembley who was a mathematician. Trembley initiated studies with the freshwater hydrozoan, hydra to determine if the organism was a plan...

Download PDF file
  • EP ID EP721418
  • DOI https://doi.org/10.46889/JRMBR.2023.4301
  • Views 14
  • Downloads 0

How To Cite

Hetvi Solanki1, Vincent S Gallicchio1* (2023). Use of Stem Cells to Treat Left Ventricular Hypertrophy. Journal of Regenerative Medicine & Biology Research, 4(3), -. https://europub.co.uk/articles/-A-721418